The Department of Endocrinology, 
Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone?
- Department of Endocrinology, Christian Medical College and Hospital, Ludhiana, Punjab, 141008, India. jubbin.jacob@gmail.com.
- Department of Endocrinology, Diabetes and Metabolism, Christian Medical College and Hospital, Vellore, Tamil Nadu, India.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA Vol. 33 · Issue 6 · pp. 1397-1399
PMID 35181823 DOI 10.1007/s00198-021-06271-0
Cite This Article
Jubbin Jagan Jacob, Thomas V Paul. Romosozumab and cardiovascular safety-should we learn lessons from pioglitazone?. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA. 2022;33(6):1397-1399. doi:10.1007/s00198-021-06271-0
Keywords
- Antibodies
- Monoclonal
- Bone Density
- Bone Density Conservation Agents
- Humans
- Osteoporosis
- Pioglitazone
